DTX3L Enhances Type I Interferon Antiviral Response by Promoting the Ubiquitination and Phosphorylation of TBK1

Our present study evaluated DTX3L as an antiviral molecule by promoting IFN production and establishing an IFN-β–ETS1–DTX3L–TBK1 positive-feedback loop as a novel immunomodulatory step to enhance interferon signaling and inhibit respiratory syncytial virus (RSV) infection. Our finding enriches and complements the biological function of DTX3L and provides a new strategy to protect against lung diseases such as bronchiolitis and pneumonia that develop with RSV. ABSTRACT Studies already revealed that some E3 ubiquitin ligases participated in the immune response after viral infection by regulating the type I interferon (IFN) pathway. Here, we demonstrated that type I interferon signaling enhanced the translocation of ETS1 to the nucleus and the promoter activity of E3 ubiquitin ligase DTX3L (deltex E3 ubiquitin ligase 3L) after virus infection and thus increased the expression of DTX3L. Further experiments suggested that DTX3L ubiquitinated TBK1 at K30 and K401 sites on K63-linked ubiquitination pathway. DTX3L was also necessary for mediating the phosphorylation of TBK1 through binding with the tyrosine kinase SRC: both together enhanced the activation of TBK1. Therefore, DTX3L, being an important positive-feedback regulator of type I interferon, exerted a key role in antiviral response. IMPORTANCE Our present study evaluated DTX3L as an antiviral molecule by promoting IFN production and establishing an IFN-β–ETS1–DTX3L–TBK1 positive-feedback loop as a novel immunomodulatory step to enhance interferon signaling and inhibit respiratory syncytial virus (RSV) infection. Our finding enriches and complements the biological function of DTX3L and provides a new strategy to protect against lung diseases such as bronchiolitis and pneumonia that develop with RSV.

[1]  A. Brazma,et al.  The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences , 2021, Nucleic Acids Res..

[2]  N. Jouvenet,et al.  Stimulation of Innate Immunity by Host and Viral RNAs. , 2019, Trends in immunology.

[3]  L. Kauvar,et al.  Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity , 2019, Front. Immunol..

[4]  M. Proesmans,et al.  New therapies for acute RSV infections: where are we? , 2019, European Journal of Pediatrics.

[5]  Wei Xu,et al.  TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production , 2018, Front. Immunol..

[6]  Louise A. Carolan,et al.  Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection , 2017, Journal of Virology.

[7]  Yuxiang Sun,et al.  Effects of DTX3L on the cell proliferation, adhesion, and drug resistance of multiple myeloma cells , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[8]  Mahmut Parlak,et al.  Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9. , 2017, Molecular cell.

[9]  Yue Xue,et al.  E3 ligase FBXW7 is critical for RIG-I stabilization during antiviral responses , 2017, Nature Communications.

[10]  Taoyong Chen,et al.  The tyrosine kinase Src promotes phosphorylation of the kinase TBK1 to facilitate type I interferon production after viral infection , 2017, Science Signaling.

[11]  P. Wang,et al.  E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1 , 2016, Nature Immunology.

[12]  P. Hassa,et al.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review , 2015, Molecular Cancer.

[13]  M. Holtzman,et al.  PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection , 2015, Nature Immunology.

[14]  S. Akira,et al.  Alveolar macrophage–derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes , 2015, The Journal of experimental medicine.

[15]  P. Hassa,et al.  DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells , 2014, Molecular Cancer.

[16]  B. Sankaran,et al.  Structural insights into the functions of TBK1 in innate antimicrobial immunity. , 2013, Structure.

[17]  T. Maniatis,et al.  Crystal structure and mechanism of activation of TANK-binding kinase 1. , 2013, Cell reports.

[18]  W. Hahn,et al.  Structure and ubiquitination-dependent activation of TANK-binding kinase 1. , 2013, Cell reports.

[19]  S. Akira,et al.  IPS-1 Signaling Has a Nonredundant Role in Mediating Antiviral Responses and the Clearance of Respiratory Syncytial Virus , 2012, The Journal of Immunology.

[20]  M. Shipp,et al.  BAL1 and Its Partner E3 Ligase, BBAP, Link Poly(ADP-Ribose) Activation, Ubiquitylation, and Double-Strand DNA Repair Independent of ATM, MDC1, and RNF8 , 2012, Molecular and Cellular Biology.

[21]  H. Shu,et al.  Glycogen synthase kinase 3β regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. , 2010, Immunity.

[22]  M. Shipp,et al.  BBAP monoubiquitylates histone H4 at lysine 91 and selectively modulates the DNA damage response. , 2009, Molecular cell.

[23]  Nan Li,et al.  The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon , 2009, Nature Immunology.

[24]  O. Ramilo,et al.  MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus , 2008, Proceedings of the National Academy of Sciences.

[25]  Bryan R. G. Williams,et al.  Interferon-inducible antiviral effectors , 2008, Nature Reviews Immunology.

[26]  Dakang Xu,et al.  Transcriptional Regulation of Telomerase Activity , 2007, Annals of the New York Academy of Sciences.

[27]  R. Peebles,et al.  Differential Type I Interferon Induction by Respiratory Syncytial Virus and Influenza A Virus In Vivo , 2007, Journal of Virology.

[28]  Robert E Black,et al.  WHO estimates of the causes of death in children , 2005, The Lancet.

[29]  Ricardo C T Aguiar,et al.  The BAL-binding Protein BBAP and Related Deltex Family Members Exhibit Ubiquitin-Protein Isopeptide Ligase Activity* , 2003, Journal of Biological Chemistry.

[30]  R. H. Smith,et al.  A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. , 1997, Journal of immunological methods.

[31]  J. Garssen,et al.  University of Groningen Respiratory Syncytial Virus Induced Type I IFN Production by pDC Is Regulated by RSV- Infected Airway Epithelial Cells, RSV-Exposed Monocytes and Virus Specific Antibodies Schijf, , 2013 .

[32]  Igor Rudan,et al.  Epidemiology and etiology of childhood pneumonia. , 2008, Bulletin of the World Health Organization.

[33]  S. Goodbourn,et al.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. , 2008, The Journal of general virology.